GW Pharmaceuticals (GW) develops medicines derived from the cannabis plant that have the potential to treat a plethora of disorders including pain and spasm in multiple sclerosis, spinal cord injury, neuropathic pain, arthritis, stroke and head injury, AIDS, nausea, migraine and cancer pain. GW’s research is based upon evidence that suggests that cannabis and cannabinoids provide benefit to patients suffering from medical conditions.